CLINICAL_TRIALS
trial_result
· 2012-07-27
Clinical Trial Update: Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV) [Phase 2]
Summary
Phase 2 dose-finding trial of taribavirin for chronic hepatitis C completed; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch Health Americas, Inc. | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2012-07-27